openPR Logo
Press release

Desmoid Tumors Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2034, estimates DelveInsight

04-22-2025 07:46 AM CET | Health & Medicine

Press release from: ABNewswire

Desmoid Tumors Treatment Market Size in 7MM is expected to grow

DelveInsight's "Desmoid Tumors Market Insight, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of desmoid tumor, historical and forecasted epidemiology as well as the desmoid tumors market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

Unlock key insights into the Desmoid Tumors Market! Download DelveInsight's comprehensive report to explore market trends, pipeline analysis, and emerging therapies @ Desmoid Tumors Market Size [https://www.delveinsight.com/sample-request/desmoid-tumors-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]

Key Takeaways from the Desmoid Tumors Market Report

* In April 2025, M.D. Anderson Cancer Center conducted a study of the safety and effects of an investigational drug called nirogacestat when given to participants with a desmoid tumor/aggressive fibromatosis.
* In April 2025, Children's Oncology Group announced a phase II trial studies the side effects and how well nirogacestat works in treating patients less than 18 years of age with desmoid tumors that has grown after at least one form of treatment by mouth or in the vein that cannot be removed by surgery. Nirogacestat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
* Desmoid tumors account for



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Desmoid Tumors Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2034, estimates DelveInsight here

News-ID: 3980569 • Views:

More Releases from ABNewswire

Mobiniti Zaps Trigger
Mobiniti Zaps Trigger "Thank-You SMS" After Successful Debt Consolidation Opt-In …
Gratitude goes a long way-especially when a subscriber takes the first step toward financial stability. With automatic thank-you messages triggered upon opt-in to debt consolidation programs, Mobiniti ensures every contact feels acknowledged and welcomed right from the start. These real-time SMS replies boost engagement, encourage next steps, and foster a sense of trust immediately after signup. Image: https://www.abnewswire.com/upload/2025/11/838fe0640a43d0ee12110716c6f782f8.jpg Instant Gratitude, Automatically Delivered When a contact joins a debt relief or consolidation list, a
Besterrabatt.de Launches Verified Discount Code Platform - Discover Exclusive Deals and Top Offers Across Every Category
Besterrabatt.de Launches Verified Discount Code Platform - Discover Exclusive De …
Besterrabatt.de introduces a verified coupon and promo code platform that provides users with 100% working discount codes for shopping, travel, gaming, beauty, and more. Every offer is manually verified to ensure authenticity, helping customers find exclusive deals and save money across their favorite brands. Explore verified coupons and top offers today at Besterrabatt.de Berlin, Germany - November 12, 2025 - Besterrabatt.de [https://besterrabatt.de/] today announced the launch of its verified discount and
Top HR Automation Software for Enterprise (2025 Edition)
Top HR Automation Software for Enterprise (2025 Edition)
Image: https://www.abnewswire.com/upload/2025/11/934e8571ed57655bd702d6a7d09c0e64.jpg Introduction: Why HR Automation Matters More Than Ever Enterprise HR has outgrown spreadsheets, ad-hoc workflows, and disconnected point tools. Modern hr automation software [https://www.bitrix24.com/tools/hr_automation/] must power a stack that automates end-to-end employee journeys - recruitment, onboarding, time and pay, performance, learning, mobility, and offboarding - while enforcing compliance, delivering consumer-grade experiences, and producing audit-ready data in real time. Done well, HR automation cuts manual touches by 30-60%, shortens time-to-hire and
Referanskodu.tr Officially Launches Verified Referral & Invite Code Platform Empowering Users to Earn Real Rewards in Crypto, Gaming, and Travel
Referanskodu.tr Officially Launches Verified Referral & Invite Code Platform Emp …
Referanskodu.tr has launched a verified referral and invite code platform that provides users with 100% working and tested referral links across popular categories including crypto, trading, gaming, and travel. Every code is verified for authenticity, allowing users to earn real bonuses, cashback, and rewards securely. With its commitment to trust and transparency, Referanskodu.tr is set to become the world's reliable referral code destination. Istanbul, Turkey - November 12, 2025 - Referanskodu.tr

All 5 Releases


More Releases for Desmoid

Desmoid Tumors Market Future Business Scope Analysis Report, Marketing Strategy, …
Introduction The Desmoid Tumors Market focuses on a rare, locally aggressive, but non-metastatic type of soft tissue tumor that arises from fibroblasts. Also known as aggressive fibromatosis, desmoid tumors can occur anywhere in the body, but are most common in the abdomen, shoulder, and limbs. Although they do not spread to distant organs, they can cause significant morbidity due to local invasion and recurrence. Over the past decade, treatment strategies have evolved
Desmoid Tumors Market Poised for 6.8 % Growth, Set to Hit $4.13 Billion by 2029
How Are the key drivers contributing to the expansion of the desmoid tumors market? The escalating prevalence of cancer is predicted to catalyze the expansion of the desmoid tumor market. Cancer is characterized by abnormal cellular growth in the body, which can uncontrollably spread and potentially damage nearby tissues and organs. With global cancer rates climbing, there has been a corresponding surge in demand for refined chemotherapeutic agents, having a favorable
Top Factor Driving Desmoid Tumors Market Growth in 2025: Rising Global Cancer In …
How Big Is the Desmoid Tumors Market Expected to Be, and What Will Its Growth Rate Be? The desmoid tumors market is set to grow from $2.97 billion in 2024 to $3.18 billion in 2025, at a CAGR of 7.3%. Growth is driven by advancements in medical imaging, genetic research, surgical innovations, and increased awareness and education on these tumors. The desmoid tumors market is forecast to grow strongly, reaching $4.13 billion
Top Factor Driving Desmoid Tumors Market Growth in 2025: Rising Global Cancer In …
How Big Is the Desmoid Tumors Market Expected to Be, and What Will Its Growth Rate Be? The desmoid tumors market is set to grow from $2.97 billion in 2024 to $3.18 billion in 2025, at a CAGR of 7.3%. Growth is driven by advancements in medical imaging, genetic research, surgical innovations, and increased awareness and education on these tumors. The desmoid tumors market is forecast to grow strongly, reaching $4.13 billion
Desmoid Tumors Market Strategies 2024-2033: Segments, Analysis, Trends, Opportun …
"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Desmoid Tumors Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $3.84 billion In 2028 At
Desmoid Tumors Pipeline Outlook, Clinical Trials, FDA Approvals, and Companies 2 …
(Albany, United States) As per DelveInsight's assessment, globally, the Desmoid Tumors Pipeline constitutes 12+ key companies continuously working towards developing 12+ Desmoid Tumors Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight. In the Desmoid Tumors Pipeline Report, a detailed description of the drug is given which includes the mechanism of action of the drug, clinical studies, Desmoid Tumors NDA approvals (if